These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32145101)

  • 1. Fungaemia due to rare yeasts in a tertiary care university centre within 18 years.
    Alp S; Gulmez D; Ayaz CM; Arikan-Akdagli S; Akova M
    Mycoses; 2020 May; 63(5):488-493. PubMed ID: 32145101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed fungaemia: an 18-year report from a tertiary-care university hospital and a systematic review.
    Gülmez D; Alp S; Gursoy G; Ayaz CM; Dogan O; Arikan-Akdagli S; Akova M
    Clin Microbiol Infect; 2020 Jul; 26(7):833-841. PubMed ID: 32246995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center.
    Marcos-Zambrano LJ; Escribano P; Sánchez C; Muñoz P; Bouza E; Guinea J
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4565-72. PubMed ID: 24867979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
    Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
    J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of Candida tropicalis fungaemia with reduced triazole susceptibility in Taiwan: a multicentre study.
    Liu WL; Huang YT; Hsieh MH; Hii IM; Lee YL; Ho MW; Liu CE; Chen YH; Wang FD
    Int J Antimicrob Agents; 2019 Feb; 53(2):185-189. PubMed ID: 30722962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
    J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of Rhodotorula mucilaginosa from blood cultures in a tertiary care hospital.
    Falces-Romero I; Cendejas-Bueno E; Romero-Gómez MP; García-Rodríguez J
    Mycoses; 2018 Jan; 61(1):35-39. PubMed ID: 28922488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.
    Arendrup MC; Dzajic E; Jensen RH; Johansen HK; Kjaeldgaard P; Knudsen JD; Kristensen L; Leitz C; Lemming LE; Nielsen L; Olesen B; Rosenvinge FS; Røder BL; Schønheyder HC
    Clin Microbiol Infect; 2013 Aug; 19(8):E343-53. PubMed ID: 23607326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study.
    González GM; Treviño-Rangel Rde J; Palma-Nicolás JP; Martínez C; González JG; Ayala J; Caballero A; Morfín-Otero R; Rodríguez-Noriega E; Velarde F; Ascencio EP; Tinoco JC; Vázquez JA; Cano MA; León-Sicairos N; González R; Rincón J; Elías MA; Bonifaz A
    J Antimicrob Chemother; 2013 Dec; 68(12):2847-51. PubMed ID: 23869052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry.
    Durán Graeff L; Seidel D; Vehreschild MJ; Hamprecht A; Kindo A; Racil Z; Demeter J; De Hoog S; Aurbach U; Ziegler M; Wisplinghoff H; Cornely OA;
    Mycoses; 2017 Apr; 60(4):273-279. PubMed ID: 28150341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes.
    Ruan SY; Huang YT; Chu CC; Yu CJ; Hsueh PR
    Int J Antimicrob Agents; 2009 Sep; 34(3):236-9. PubMed ID: 19361960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A first Portuguese epidemiological survey of fungaemia in a university hospital.
    Costa-de-Oliveira S; Pina-Vaz C; Mendonça D; Gonçalves Rodrigues A
    Eur J Clin Microbiol Infect Dis; 2008 May; 27(5):365-74. PubMed ID: 18204871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of fungemia caused by Candida and non-Candida rare yeasts: a retrospective study from a tertiary care hospital.
    Oz Y; Yılmaz M; Bulduk T; Basayigit M; Gunduz E; Metintas S
    Med Mycol; 2024 May; 62(5):. PubMed ID: 38627248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.
    Bayramoglu G; Sonmez M; Tosun I; Aydin K; Aydin F
    Infection; 2008 Feb; 36(1):68-70. PubMed ID: 17882360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.
    Kimura M; Araoka H; Yamamoto H; Nakamura S; Nagi M; Yamagoe S; Miyazaki Y; Ogura S; Mitsuki T; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Shimazu H; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Wake A; Taniguchi S; Yoneyama A
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.